5 Tell Tale Signs You are Ready for an eTMF inspection - Agatha eTMF software

Agathalife EN

/@Agathalife_EN

Published: May 5, 2021

Open in YouTube
Insights

This video provides an in-depth exploration of Electronic Trial Master File (eTMF) systems, focusing on the critical indicators that signal an organization's readiness for such a system and the essential features to consider during implementation. Ken Lowney, Head of North American Operations for Agatha, guides the audience through the evolution of eTMF technology, from its early platforms to modern, user-centric applications. The presentation aims to demystify eTMF, highlight its core functionalities, and offer practical advice for internal advocacy and successful adoption within life sciences companies.

The discussion begins by establishing the fundamental concept of a Trial Master File (TMF) as the central repository for all essential documents proving the conduct and evaluation of a clinical trial, as defined by ICH guidelines. Lowney then traces the evolution of eTMF systems through four distinct generations: starting with custom-built, on-premise platforms in the 1990s (like Documentum), transitioning to SharePoint-based solutions, then to cloud-based platforms (like Veeva), and finally to the current "fourth generation" of purpose-built applications. This latest generation emphasizes ease of use, rapid deployment, and a lower cost of ownership, moving away from complex, expensive platforms that primarily benefited IT departments rather than end-users.

A significant portion of the webinar is dedicated to identifying five "telltale signs" that indicate an organization is not only ready but needs an eTMF system. These signs address common operational inefficiencies, compliance risks, growth trajectories, and strategic business considerations such as mergers and acquisitions. Lowney outlines the minimum essential features that any modern eTMF system must possess, including regulatory compliance (e.g., 21 CFR Part 11), adherence to the TMF Reference Model, robust workflows, and comprehensive document management capabilities. The presentation concludes with practical advice on building internal support for an eTMF initiative, emphasizing cost-benefit analysis, risk mitigation, and a phased implementation approach.

Key Takeaways:

  • TMF is a Regulatory Requirement: The Trial Master File (TMF) is a mandatory collection of essential documents that permit the evaluation and conduct of a clinical trial, explicitly required by EU regulations and implicitly by US regulations due to inspection readiness requirements. It serves as evidence of trial execution years later.
  • eTMF is a System, Not Just a File Cabinet: An Electronic Trial Master File (eTMF) is more than just digital documents; it encompasses the system and processes for collecting, reviewing, approving, and signing off on trial artifacts. It must include audit trails, version management, and electronic signatures to be compliant.
  • Evolution of eTMF Technology: eTMF systems have evolved through four generations: 1) 1990s on-premise platforms (e.g., Documentum), 2) SharePoint-based solutions, 3) Cloud-based platforms (e.g., Veeva), and 4) Modern "apps" focused on usability, faster implementation, and lower cost, moving away from complex, IT-centric platforms.
  • Five Signs of eTMF Readiness: Organizations are ready for an eTMF if they are: 1) using non-compliant tools (shared folders, Box, email, FTP) for document management, 2) facing headcount issues due to manual document processes, 3) worried about audit or inspection readiness, 4) experiencing a ramp-up in clinical trial activity (first trial, later phases, insourcing from CRO), or 5) preparing for potential M&A or investment activity requiring robust due diligence.
  • Core Capabilities of a Modern eTMF: Essential features include: 21 CFR Part 11 and other regulatory compliance, leveraging the TMF Reference Model, ready-to-use templates/forms, role-based access control, review and approval workflows, automatic version management, import/export functionality, "what's missing" reporting, and collaborative authoring.
  • TMF Reference Model is Key: While every organization's TMF is unique, the publicly available TMF Reference Model provides a standard starting point for content, naming, structure, and metadata, which can then be customized to create a master template for specific study documents.
  • Fourth Generation Differentiators: Usability and Speed: Beyond core functions, the key differentiators for modern eTMF systems are exceptional usability, ease of use, and speed of implementation (measured in weeks/months, not years). These "apps" are designed for occasional users and smaller organizations, unlike older systems built for dedicated, full-time staff.
  • Building Internal Support for eTMF: Advocate for eTMF by focusing on cost-benefit analysis (subscription model, cost avoidance of new hires), risk avoidance (compliance, M&A due diligence), and efficiency gains (accelerating study startup, reducing wasted staff time).
  • Current State/Future State Analysis: Present the eTMF initiative using a current state vs. desired future state analysis, acknowledging that implementation might occur in phases (e.g., starting with one study) and involve a core team and an extended stakeholder group.
  • Integration with Other Clinical Systems: Modern eTMF apps can integrate effectively with other clinical operations systems (CTMS, EDC) using standard REST APIs, challenging the notion that all systems must come from a single "platform" vendor for seamless operation.
  • eTMF vs. QMS Implementation: While a Quality Management System (QMS) is crucial, for clinical-stage companies, implementing an eTMF early can prevent the massive task of organizing trial documents retrospectively, making it a foundational component of overall quality management for clinical activities.
  • Site Access to eTMF: While direct site access to the eTMF is technically possible, it often creates usability challenges for site staff. A better model involves a companion app or workspace for sites to manage their binder documents, with controlled and precise transfer of relevant documents to the sponsor's/CRO's eTMF.
  • Email and Document Management: eTMF systems should allow storage of emails as artifacts. Advanced systems may offer "mail-in" functionality, allowing direct forwarding of emails into the eTMF for subsequent processing and categorization.
  • In-Application Document Editing: Modern eTMF systems are moving beyond simply opening external applications (like Microsoft Word) for editing. The latest generation allows direct editing of documents within the eTMF application itself, similar to cloud-based document editors, for a more streamlined user experience.

Tools/Resources Mentioned:

  • Document Management Platforms (Historical): Documentum, OpenText, Filenet
  • Ubiquitous Platforms: SharePoint, Box, Dropbox, FTP
  • Cloud-based eTMF Pioneers: Veeva
  • Office Productivity: Microsoft Word (specifically Word 365), Google Docs
  • Integration Technology: REST API (Restful Application Programming Interface)
  • Agatha Products: Agatha eTMF, Agatha Remote Monitoring System, Agatha SOP Management System, Agatha Quality Solution (for deviations, CAPA, audit prep)
  • Industry Resource: CenterWatch
  • Regulatory Standard: ICH (International Council for Harmonisation)
  • US Regulatory Compliance: 21 CFR Part 11
  • eTMF Standard: TMF Reference Model

Key Concepts:

  • Trial Master File (TMF): The collection of essential documents that individually and collectively permit the evaluation of the conduct of a clinical trial and the quality of the data produced.
  • Electronic Trial Master File (eTMF): A computer-based system for managing the TMF, encompassing not just documents but also the processes (workflows, audit trails, electronic signatures) for their management.
  • ICH (International Council for Harmonisation): An international body that brings together regulatory authorities and the pharmaceutical industry to discuss scientific and technical aspects of drug registration.
  • 21 CFR Part 11: Regulations issued by the FDA that set forth the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures.
  • TMF Reference Model: A standardized, publicly available framework that defines the essential documents, their naming, structure (folder hierarchy), and metadata for a TMF, serving as a common starting point for customization.
  • Audit Trail: A chronological record of electronic events, including who accessed what, when, and what changes were made, essential for regulatory compliance.
  • Version Management: The process of tracking and controlling changes to documents, ensuring that all drafts, interim versions, and final versions are recorded and accessible.
  • Role-Based Access Control (RBAC): A security mechanism that restricts system access based on the roles of individual users within an organization, ensuring users only see and interact with what they are authorized to.
  • Workflow: A sequence of tasks or steps required to complete a process, often automated in eTMF systems for document review and approval.
  • Collaborative Authoring: The ability for multiple users to work on and contribute to the same document simultaneously or sequentially, with tracking of changes and comments.
  • Current State/Future State Analysis: A business analysis technique used to understand the existing processes and systems ("as-is" state) and define the desired future processes and systems ("to-be" state) to identify gaps and plan improvements.
  • REST API: A set of rules and standards for building and interacting with web services, enabling different software applications to communicate and exchange data easily.
  • CTMS (Clinical Trial Management System): Software used to manage and track various aspects of clinical trials, such as planning, participant recruitment, site management, and regulatory submissions.
  • EDC (Electronic Data Capture): Software used to collect clinical trial data from participants at investigator sites.
  • QMS (Quality Management System): A formalized system that documents processes, procedures, and responsibilities for achieving quality policies and objectives, often including SOPs, deviations, and CAPAs.
  • SOP (Standard Operating Procedure): Detailed, written instructions to achieve uniformity of the performance of a specific function.